Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aptamer GroupFRA:P0J Days Payable is 252.51 as of Dec. 2025, which is 87% above its 10-year median of 134.96. The stock has 4 warning signs investors should review. Among 701 Biotechnology companies, Aptamer Group ranks better than 67.76% on this metric.
The historical rank and industry rank for Aptamer Group's Days Payable or its related term are showing as below:
FRA:P0J'
s Days Payable Range Over the Past 10 Years
Min: 54.65 Med: 134.96 Max: 331.49
Current: 253.85
During the past 6 years, Aptamer Group's highest Days Payable was 331.49. The lowest was 54.65. And the median was 134.96.
FRA:P0J's Days Payable is ranked better than 67.76% of 701
companies
in the Biotechnology industry
Industry Median: 113.36
vs FRA:P0J: 253.85
Aptamer Group's Days Payable
declined
from Dec. 2024 (290.15) to Dec. 2025 (252.51).
It may suggest that Aptamer Groupaccelerated paying its suppliers.
Aptamer Group Days Payable Related Terms
Aptamer Group Days Payable Historical Data
* Premium members only.
The historical data trend for Aptamer Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:P0J vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Aptamer Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aptamer Group Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aptamer Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Aptamer Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Aptamer Group's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aptamer Group (FRA:P0J) has a Days Payable of 252.51 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aptamer Group and its competitors. This is 87% above median its historical median of 134.96. Over the past decade, Aptamer Group's Days Payable has ranged from 54.65 to 331.49. According to the industry distribution chart, Aptamer Group ranks #226 out of 701 companies in the Biotechnology industry, placing it in the top 32.2%.
Is Aptamer Group's Days Payable too high?
Aptamer Group's current Days Payable of 252.51 is 87% above median its 10-year median of 134.96. Over the past 10 years, this metric has ranged from a low of 54.65 to a high of 331.49. The Biotechnology industry median Days Payable is 113.36. Aptamer Group's value of 252.51 is 122.8% above this industry median. Based on the distribution chart, Aptamer Group ranks #226 out of 701 companies in the Biotechnology industry, which is above the industry midpoint.
How does Aptamer Group's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aptamer Group ranks #226 out of 701 companies for Days Payable. This puts Aptamer Group in the upper half of its industry. The industry median Days Payable is 113.36. Aptamer Group's value of 252.51 is 122.8% above this benchmark. Historically, Aptamer Group's own Days Payable has ranged from 54.65 to 331.49 over the past decade. While the company's 10-year median is 134.96 vs. the industry median of 113.36, Aptamer Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.36, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aptamer Group's current Days Payable of 252.51 is 122.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aptamer Group and its competitors. For the Biotechnology industry, the median Days Payable is 113.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aptamer Group's current Days Payable is 252.51, which is 87% above median its own 10-year median of 134.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptamer Group stock overvalued right now?
Aptamer Group (FRA:P0J) has a current Days Payable of 252.51. The current Days Payable is 252.51, which is 87% above median its 10-year median of 134.96 and 122.8% above the Biotechnology industry median of 113.36. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Aptamer Group (FRA:P0J), the current Days Payable is 252.51 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses, Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics. The Group represents a single operating segment being research and experimental development of biotechnology. It operates in United Kingdom, Europe, USA and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:P0J has been successfully added to your 
